Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • Zaag
    replied
    Yeah we do that but on the 454-FLX+ so no junior here. I am not sure what exactly are the differences regarding emPCR and such, but if you have questions just mail me, or ask them here (mail is faster answer).

    Leave a comment:


  • CCBIO
    Guest replied
    Ok.Thank you very much for your reply. I was wondering if you also perform SeqCap EZ Choice...I have a lot of question regarding this method but I don't think many people of this forum perform SeqCap and then run on a GS Junior platform

    Leave a comment:


  • Zaag
    replied
    That would be a small volume emulsion. They come in three sizes, small medium and large.

    Leave a comment:


  • CCBIO
    Guest replied
    Can I ask you what is SVE?

    Leave a comment:


  • Zaag
    replied
    After sequence capture I usually end up between 1 and 2 cpb; so if you measured your sample with a Qubit before calculating the nr of molecules my guess would be that 1cpb would be a safe number.

    Usually I do one SVE with 1 cpb and one with 2 cpb and after calculating enrichment I choose a cpb for my bulk emulsion.

    Leave a comment:


  • CCBIO
    Guest replied
    Ok, thank you Zaag. May I ask you how many copy per bead do you use in emPCR lib L? I would start trying 1 cpb since it is the first time that I perform this emPCR. Do you have any suggestion?

    Leave a comment:


  • Zaag
    replied
    No you don't, after LM-PCR only 1 of the strands will be able to get PCRed on the bead.

    Leave a comment:


  • CCBIO
    started a topic NimbleGen SeqCap and empPCR lib L

    NimbleGen SeqCap and empPCR lib L

    Dear all, I performed sequence capture of target exons using NimbleGen SeqCap EZ strategy. Now I have to proceed to emPCR (Lib L). Should I denature my for 95 C degrees for 2 minutes?

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
53 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
40 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Working...